11212017Headline:

St. Petersburg, Florida

HomeFloridaSt. Petersburg

Email Joseph H. Saunders Joseph H. Saunders on LinkedIn Joseph H. Saunders on Facebook Joseph H. Saunders on Avvo
Joseph H. Saunders
Joseph H. Saunders
Attorney • (800) 748-7115

Novartis' Diabetes Drug Galvus

Comments Off

Novartis AG has decided to delay it diabetes drug Galvus because of concerns with liver toxicity problems. The drug is supposed to compete favorably with Merck’s diabetes drug Januvia but problems with high dosage of Galvus has forced its delay to the market. Januvia is a once daily diabetes drug that works in a similar fashion to Galvus but doesn’t have the same liver toxicity concerns as Galvus.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.